STATEMENT ON SCHEDULE 13G
This is Amendment No. 1 to the Schedule 13G filed with the Securities and Exchange Commission on February 14, 2020. Pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended (the “Act”), each of the persons listed below under Item 2 (each a “Reporting Person,” and collectively the “Reporting Persons”), have agreed to file one statement with respect to their beneficial ownership of common stock, par value $0.001 per share (“Common Stock”), of Change Healthcare Inc. (the “Issuer”).
Item 1.
Change Healthcare Inc.
(b) | Address of Issuer’s Principal Executive Offices: |
424 Church Street, Suite 1400
Nashville, TN 37219
Item 2.
(a) | Name of Person Filing: |
Hellman & Friedman LLC
Hellman & Friedman Investors VI, L.P.
H&F Harrington AIV II, L.P.
HFCP VI Domestic AIV, L.P.
Hellman & Friedman Capital Executives VI, L.P.
Hellman & Friedman Capital Associates VI, L.P.
(b) | Address of Principal Business Office, or, if None, Residence: |
The principal business office for all persons filing:
415 Mission Street, Suite 5700
San Francisco, CA 94105
See Item 4 of each cover page.
(d) | Title of Class of Securities: |
Common stock, par value $0.001 per share.
15912K100
Item 3.
Not applicable.
(a) | Amount beneficially owned: 0 |